- Filed
- Aug 5, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 25, 2024 | 71.32M sh |
| Long Term Debt | Q1 2025 · Jun 30, 2024 | $75M |
| Long Term Debt | Q1 2025 · Mar 31, 2024 | $100M |
| Cash And Equivalents | Q1 2025 · Jun 30, 2024 | $362.21M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $389.67M |
| Current Liabilities | Q1 2025 · Jun 30, 2024 | $383.2M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $395.08M |
| Total Liabilities | Q1 2025 · Jun 30, 2024 | $653.42M |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $703.24M |
| Current Assets | Q1 2025 · Jun 30, 2024 | $590.05M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $672.49M |
| Total Assets | Q1 2025 · Jun 30, 2024 | $2.09B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $2.6B |
| Shares Diluted | Q1 2025 · Jun 30, 2023 | 71.54M sh |
| Stock Repurchased | Q1 2025 · Jun 30, 2023 | $0 |
| Capex restated | Q1 2025 · Jun 30, 2023 | $1.96M |
| Operating Cash Flow | Q1 2025 · Jun 30, 2023 | −$22.37M |
| Stockholders Equity | Q1 2025 · Jun 30, 2023 | $2.03B |
| Stockholders Equity | Q1 2025 · Mar 31, 2023 | $2.03B |
| Eps Diluted | Q1 2025 · Jun 30, 2023 | −$0.06 |
| Eps Basic | Q1 2025 · Jun 30, 2023 | −$0.06 |
| Sga Expense | Q1 2025 · Jun 30, 2023 | $28.21M |
| Rd Expense | Q1 2025 · Jun 30, 2023 | $45.52M |
| Net Income | Q1 2025 · Jun 30, 2023 | −$4.2M |
| Operating Income | Q1 2025 · Jun 30, 2023 | −$4.7M |
| Gross Profit | Q1 2025 · Jun 30, 2023 | $160.74M |
| Cost Of Revenue | Q1 2025 · Jun 30, 2023 | $50.4M |
| Revenue | Q1 2025 · Jun 30, 2023 | $211.14M |